{
  "ticker": "JAT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968633",
  "id": "02968633",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250711",
  "time": "1359",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lqc6ld23n5n0.pdf",
  "summary": "### **Material Information Summary: Jatcorp (ASX: JAT) \u2013 Preliminary FY2025 Loss Guidance**  \n\n- **FY2025 Unaudited Net Loss**: **$7.6M\u2013$8M** (vs. $6.1M H1 loss, signaling worsening performance).  \n- **Key Drivers**:  \n  - **Revenue Decline**: ~$39M drop due to **Neurio China suspension** (legal dispute) & discontinued international operations.  \n  - **Impairments**: **$2.35M goodwill** (Sunnya CGU) + **$1.4M inventory write-downs** (Neurio-related).  \n  - **Legal Costs**: **$4.1M** (Neurio dispute; down $1M YoY but still material).  \n- **FY26 Outlook**:  \n  - Focus on **Moroka brand growth**; distributor (H&S International) targets **$11M FY26 sales** (+22% vs. FY25).  \n- **No mention of capital raising, liquidity concerns, or balance sheet details**.  \n\n**Omitted**: Operational restructuring details, registered office correction, forward-looking non-financial strategies.  \n\n*Summary Type: Earnings Guidance (Preliminary Loss)*",
  "usage": {
    "prompt_tokens": 1364,
    "completion_tokens": 263,
    "total_tokens": 1627,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T04:51:46.271475"
}